@FierceBiotech: RegenX IPO raises $138M, renewing hopes for a big Q4 biotech run. Article | Follow @FierceBiotech
@JohnCFierce: Allergan and Richter win FDA approval for a once-rejected schizophrenia pill. News | Follow @JohnCFierce
> Mapp Biopharmaceutical secured the FDA's fast-track status for ZMapp, its in-development treatment for Ebola virus. News
> Aduro Biotech ($ADRO) has leased a 56,000-square-foot space in Berkeley to house its R&D efforts as it moves forward with a pipeline of immuno-oncology treatments. Story
> Roche ($RHHBY) has constructed a 41-story skyscraper in its native Basel, a move that "can be seen as a defiant reaction to the arrival of others moving into a space Roche has dominated for the last 15 years," an analyst told Reuters. More
Medical Device News
@FierceMedDev: ICYMI yesterday: U.K. scientists develop ultrasonic device to better clean medical instruments. Article | Follow @FierceMedDev
@EmilyWFierce: Jaychem Industries is feeling the burn from an FDA warning letter over its GolfersSkin Sunscreen. FiercePharmaManufacturing story | Follow @EmilyWFierce
> Penumbra goes public in upsized $120M deal, med tech's largest IPO of 2015. Story
> Upstart Establishment gets $20M+ to bring safer breast implants with nanotech, RFID tracking to U.S. Article
> FDA cautions against improperly cleaned bronchoscope devices. More
Pharma News
@FiercePharma: India's Sun Pharma makes $48M purchase of eyecare firm InSite Vision. FiercePharmaAsia item | Follow @FiercePharma
@EricPFierce: Ireland pharma biz going to the dogs, so to speak. Nextvet picks up biologics plant there. FiercePharmaManufacturing item | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Perrigo officially rejects Mylan's 'insulting,' 'ego'-driven buyout offer. Item | Follow @CarlyHFierce
> Perrigo CEO has slammed Mylan for months--but he owns its shares. More
> FDA asks Pfizer for Zoloft label update highlighting birth defect risks. Story
> Allergan and Richter's antipsychotic gets FDA OK but faces stiff competition. Article